DE2707135A1 - Pyridoxinderivate, verfahren zu deren herstellung und dieselben enthaltendes mittel - Google Patents

Pyridoxinderivate, verfahren zu deren herstellung und dieselben enthaltendes mittel

Info

Publication number
DE2707135A1
DE2707135A1 DE19772707135 DE2707135A DE2707135A1 DE 2707135 A1 DE2707135 A1 DE 2707135A1 DE 19772707135 DE19772707135 DE 19772707135 DE 2707135 A DE2707135 A DE 2707135A DE 2707135 A1 DE2707135 A1 DE 2707135A1
Authority
DE
Germany
Prior art keywords
methyl
salts
pyridine
oxy
piperazinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19772707135
Other languages
German (de)
English (en)
Inventor
Jean-Pierre Maffrand
Jean-Marie Pereillo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parcor SARL
Original Assignee
Parcor SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor SARL filed Critical Parcor SARL
Publication of DE2707135A1 publication Critical patent/DE2707135A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19772707135 1976-02-20 1977-02-18 Pyridoxinderivate, verfahren zu deren herstellung und dieselben enthaltendes mittel Ceased DE2707135A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7604825A FR2341311A1 (fr) 1976-02-20 1976-02-20 Derives de la pyridoxine

Publications (1)

Publication Number Publication Date
DE2707135A1 true DE2707135A1 (de) 1977-08-25

Family

ID=9169423

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772707135 Ceased DE2707135A1 (de) 1976-02-20 1977-02-18 Pyridoxinderivate, verfahren zu deren herstellung und dieselben enthaltendes mittel

Country Status (10)

Country Link
JP (1) JPS6042792B2 (da)
BE (1) BE851461A (da)
DE (1) DE2707135A1 (da)
DK (1) DK146509C (da)
ES (1) ES456048A1 (da)
FR (1) FR2341311A1 (da)
GB (1) GB1533954A (da)
IE (1) IE44696B1 (da)
LU (1) LU76787A1 (da)
NL (1) NL7701666A (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031475A2 (en) * 1995-04-07 1996-10-10 Sibia Neurosciences, Inc. Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
WO2024084056A1 (en) * 2022-10-21 2024-04-25 Etherna Immunotherapies Nv Ionizable lipids

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2428640A1 (fr) * 1978-06-12 1980-01-11 Parcor Derives de pyridoxine, leur procede de preparation et leur application therapeutique
JPH0515517U (ja) * 1991-07-31 1993-02-26 日本電気株式会社 一次放射器取付け構造

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
C.A., 75, 151780 d, 1971 *
FR-PS 67 07 M *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031475A2 (en) * 1995-04-07 1996-10-10 Sibia Neurosciences, Inc. Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
WO1996031475A3 (en) * 1995-04-07 1997-02-06 Sibia Neurosciences Inc Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
WO2024084056A1 (en) * 2022-10-21 2024-04-25 Etherna Immunotherapies Nv Ionizable lipids

Also Published As

Publication number Publication date
NL7701666A (nl) 1977-08-23
GB1533954A (en) 1978-11-29
ES456048A1 (es) 1978-02-16
DK146509B (da) 1983-10-24
IE44696B1 (en) 1982-02-24
LU76787A1 (da) 1977-07-06
IE44696L (en) 1977-08-20
FR2341311B1 (da) 1979-10-05
JPS6042792B2 (ja) 1985-09-25
FR2341311A1 (fr) 1977-09-16
DK146509C (da) 1984-04-02
BE851461A (fr) 1977-08-16
DK69777A (da) 1977-08-21
JPS52122375A (en) 1977-10-14

Similar Documents

Publication Publication Date Title
DE2915318C2 (da)
EP0005828B1 (de) Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
CH615919A5 (da)
EP0047923B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE3441975A1 (de) 7-carboxymethoxy-furo-(3,4-c)-pyridin-derivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzung
DE2238504B2 (de) l-Phenoxy-3-alkylaminopropan-2-ol -Derivate
DE69934027T2 (de) 2-(n-cyanimino)thiazolidin-4-on derivate
DE3623300A1 (de) 7-acyloxy-6-aminoacyloxypolyoxylabdane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2261506A1 (de) Basische derivate von phenyl-1 alkanolen, ihre herstellung und diese enthaltende medikamente
DE2635961A1 (de) Therapeutisch wirksame verbindungen und verfahren zu ihrer herstellung
DE3617976A1 (de) 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
DE2707135A1 (de) Pyridoxinderivate, verfahren zu deren herstellung und dieselben enthaltendes mittel
DE2339396C2 (de) N-substituierte 1-Amino-3-phenoxypropan-2-ole, deren Salze, Verfahren zu deren Herstellung sowie Arzneimittel, die diese Verbindungen enthalten
DE1075620B (de) Verfahren zur Herstellung von Phenthiazmderivaten
DE2609746A1 (de) Piperazinverbindungen sowie arzneimittel, die diese verbindungen enthalten
DE2314335A1 (de) Neue amide der apovincaminsaeure, deren salze, herstellung und medikamente, die diese enthalten
DE2405278A1 (de) Neue 6-gamma-dialkylaminoalkoxy-4,7-dimethoxy-benzofuranderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH556354A (de) Verfahren zur herstellung von benzodioxan-derivaten.
DE2724083A1 (de) Benzo(b)furanderivate, verfahren zu deren herstellung und dieselben enthaltendes mittel
CH652401A5 (de) Amino-2,1,3-benzothiadiazol- und -benzoxadiazol-derivate, ihre herstellung und sie enthaltende arzneimittel.
DE1095836B (de) Verfahren zur Herstellung von in 10-Stellung basisch substituierten Phenthiazinderivaten
DE1915979C3 (de) 1,3-Dimethyl-xanthin-Derivate und Verfahren zu ihrer Herstellung
DE2162563C3 (de) l-(3',4'3'-Trimethoxybenzyl)-6-hydroxy-l,23,4-tetrahydroisochinoun
DD153549A5 (de) Verfahren zur herstellung von pyridinderivaten
DE2436721B2 (de) 1,3-benzodioxol-derivate, verfahren zu ihrer herstellung und arzneimittel mit einem gehalt dieser verbindungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: BARTELS, H. HELD, M., DIPL.-ING. DR.-ING., PAT.-AN

8131 Rejection